Page 9 - Unity Biotechnology Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unity biotechnology inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unity Biotechnology Inc Today - Breaking & Trending Today

Wedbush Analysts Lift Earnings Estimates for Unity Biotechnology, Inc. (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities researchers at Wedbush increased their Q2 2023 earnings per share (EPS) estimates for shares of Unity Biotechnology in a note issued to investors on Monday, May 15th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($0.70) per share for the quarter, up from […] ....

Jan Van Deursen , Nathaniel Eames David , Judith Campisi , Arete Wealth Advisors , Parkman Healthcare Partners , Unity Biotechnology Inc , Maven Securities , Unity Biotechnology , Get Rating , Healthcare Partners , Wealth Advisors , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Earnings Estimates ,

FY2026 Earnings Forecast for Unity Biotechnology, Inc. Issued By Wedbush (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities research analysts at Wedbush cut their FY2026 earnings per share (EPS) estimates for Unity Biotechnology in a research report issued to clients and investors on Tuesday, April 25th. Wedbush analyst A. Argyrides now forecasts that the company will earn ($13.02) per share for the year, down […] ....

Nathaniel Eames David , Judith Campisi , Jan Van Deursen , Acadian Asset Management , Unity Biotechnology Company Profile , Renaissance Technologies , Unity Biotechnology Inc , Virtu Financial , Unity Biotechnology , Get Rating , Asset Management , Street Corp , Exoduspoint Capital Management , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Earnings Estimates ,

Recent Investment Analysts' Ratings Changes for Unity Biotechnology (UBX)

Several analysts have recently updated their ratings and price targets for Unity Biotechnology (NASDAQ: UBX): 3/28/2023 – Unity Biotechnology had its price target lowered by analysts at Wedbush from $35.00 to $5.00. They now have an “outperform” rating on the stock. 3/28/2023 – Unity Biotechnology had its “buy” rating reaffirmed by analysts at HC Wainwright. […] ....

Nathaniel Eames David , Judith Campisi , Jan Van Deursen , News Ratings For Unity Biotechnology Inc Daily , Venture Management , Capital Management , Vanguard Group Inc , Citigroup Inc , Unity Biotechnology Inc , Unity Biotechnology , Get Rating , Asset Management , Daohong Zhou , South San Francisco , Unity Biotechnology Inc Daily , Nasdaq Ubx ,

Unity Biotechnology (NASDAQ:UBX) Price Target Cut to $5.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its target price reduced by Wedbush from $35.00 to $5.00 in a report issued on Tuesday, The Fly reports. They currently have an outperform rating on the stock. Wedbush also issued estimates for Unity Biotechnology’s FY2026 earnings at ($12.94) EPS and FY2027 earnings at ($15.07) EPS. Several other […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Renaissance Technologies , Virtu Financial , Unity Biotechnology Inc , Acadian Asset Management , Unity Biotechnology , Get Rating , Asset Management , Street Corp , Exoduspoint Capital Management , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Lower Price Target ,

Unity Biotechnology, Inc. to Post FY2026 Earnings of ($12.94) Per Share, Wedbush Forecasts (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Investment analysts at Wedbush decreased their FY2026 EPS estimates for Unity Biotechnology in a research note issued to investors on Tuesday, March 28th. Wedbush analyst A. Argyrides now anticipates that the company will earn ($12.94) per share for the year, down from their prior estimate of ($12.04). […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Schonfeld Strategic Advisors , Capital Investment Advisors , Unity Biotechnology Inc , Dimensional Fund Advisors , Unity Biotechnology , Get Rating , Street Group , Strategic Advisors , Fund Advisors , Prime Capital Investment Advisors , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Earnings Estimates ,